PHIO PHARMACEUTICALS CORP. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $40.00K.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $2.68M.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $2.15M, a 44.35% decline from fiscal 2020.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $3.86M, a 5255.56% increase from fiscal 2019.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $72.00K, a 31.43% decline from fiscal 2018.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $105.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-06-30 | $40.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.68M 10-Q · filed 2025-08-14 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $2.15M 10-K · filed 2023-03-22 | |
| 2021-03-31 | $2.15M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $3.86M 10-K · filed 2022-03-22 | |
| 2020-06-30 | $3.86M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $72.00K 10-K · filed 2021-03-25 | |
| 2019-06-30 | $17.00K 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $43.00K 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $105.00K 10-K · filed 2020-03-26 | |
| 2015-12-31 | $3.21M 10-K · filed 2017-03-30 | |
| 2014-12-31 | $166.00K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $434.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | |
| 2012-12-31 | $224.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |